Table 7.
No combination | Insulin combinations | Non-insulin combinations | Overall | |||||
---|---|---|---|---|---|---|---|---|
Ipragliflozin 50 mg | Placebo | Ipragliflozin 50 mg | Placebo | Ipragliflozin 50 mg | Placebo | Ipragliflozin 50 mg | Placebo | |
Hypoglycaemia, n/N (%) | 3/237 (1.3) | 2/215 (0.9) | 52/175 (29.7) | 13/87 (14.9) | 21/797 (2.6) | 10/494 (2.0) | 76/1209 (6.3) | 25/796 (3.1) |